<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2017</study_start_year><data_sharing_plan>IPD Sharing (as of October 2019): Yes
Description: Controlled access of study data through a reasonable request to the study management team, after a reasonable embargo period after completion of the study</data_sharing_plan><condition>Liver Regeneration</condition><condition>Colorectal Cancer Metastatic</condition><condition>Liver Cancer</condition><condition>Liver Neoplasms</condition><disease>Liver Regeneration</disease><disease>Colorectal Cancer Metastatic</disease><disease>Liver Cancer</disease><disease>Liver Neoplasms</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2248997</full_dataset_link><location>United Kingdom</location><study_start_month>9</study_start_month><keyword>Liver resection</keyword><keyword>Postoperative liver failure</keyword><keyword>Preoperative liver function</keyword><keyword>Hepatic resection</keyword><keyword>LiverMultiScan</keyword><keyword>Portal vein embolisation</keyword><keyword>Functional liver remnant</keyword><keyword>Multiparameter MRI</keyword><repository>ECRIN MDR</repository><study_status>Completed</study_status></additional><is_claimable>false</is_claimable><name>HepaT1ca: Quantifying Liver Health in Surgical Candidates for Liver Malignancies</name><description>This observational clinical cohort study aims to evaluate the clinical utility of LiverMultiScan in quantifying liver health prior to liver resection or TACE. The results will enable further developments in scanning protocols and software, and clearly define the relevance of applying this technology as part of the pre-operative assessment of the patient being considered for liver resection or TACE.</description><dates><creation>2017-09-15</creation></dates><accession>2248997</accession><cross_references><ClinicalTrials___gov>NCT03213314</ClinicalTrials___gov></cross_references></HashMap>